NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery
The New York Stem Cell Foundation Research Institute (NYSCF) and Janssen Research & Development, a Johnson & Johnson company, have partnered to accelerate the development of precision medicines for neurodegenerative diseases. NYSCF’s AI-powered platform, using automated stem cell systems, will be leveraged to identify new drug targets and therapies. This collaboration combines NYSCF’s expertise in stem cell […]
Best Stem Cell Therapy Delivery Methods Explained by Dr. Joy Kong
In the ever-evolving world of regenerative medicine, Dr. Joy Kong shines as a beacon of knowledge and innovation. In her enlightening video, The Best Delivery Methods for Stem Cell Therapy, Dr. Kong unpacks the intricate art and science of stem cell therapy, exploring how the administration of these remarkable living entities can revolutionize healing. From […]
How Stem Cell Therapy Transformed a Stroke Victim’s Life: A Journey to Recovery
Discover the incredible journey of Phil, a former marathon runner whose life took a drastic turn after a severe stroke in 2012. Despite daunting odds and years of minimal progress through traditional therapies, Phil’s life changed dramatically with the groundbreaking application of stem cell therapy. In this inspiring video, Dr. Chris Calipai shares how innovative […]
Unraveling the Difference Between Stem Cells and Exosomes
Picture yourself baking a cake. You might have a big bag of flour (stem cells) and a smaller pack of sprinkles (exosomes). Both items come from the same kitchen (the human body), yet they serve different roles. Flour can be turned into all sorts of baked goodies, while sprinkles add flair and style. That’s the […]
Dispelling the Myths of IV Stem Cell Therapy with Dr. Joy Kong
In her latest video, Dr. Joy Kong tackles a persistent myth in stem cell therapy: the idea that stem cells delivered through IV get trapped in the lungs. This outdated notion has confused patients and misled some healthcare providers for far too long. Dr. Kong dives into the science, sharing groundbreaking research and real-world insights […]
Why DIY Stem Cell Recovery Could Be Sabotaging Your Treatment Success
The journey to successful stem cell therapy doesn’t end with the injection – proper recovery is crucial for optimal results. Dr. Chris Garcia, a leading expert in stem cell recovery, explains why attempting to manage your own recovery process can significantly compromise your treatment outcomes. The Proper Recovery Timeline A structured stem cell recovery typically […]
BioCentriq Expands Cell Therapy Manufacturing
This exciting news in the cell therapy sector could revolutionize how quickly life-changing therapies reach patients. BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), is set to expand its operations and establish a cutting-edge cell therapy manufacturing facility in Princeton, New Jersey. This facility will become BioCentriq’s new headquarters, marking a significant […]
Why Stem Cell Injections Succeed or Fail: Insights from Dr. Chris Garcia
Are stem cell injections the miracle you’ve been waiting for, or just another unfulfilled promise? Dr. Chris Garcia, a leading expert in stem cell recovery, dives deep into why these innovative treatments work wonders for some but deliver lackluster results for others. Through his structured approach, he explains the three critical factors affecting success: In […]
Stem Cell Grafting: Revolutionizing Hair Restoration with Dr. Niranjan Shintre
Explore the groundbreaking science of stem cell grafting in hair restoration with Dr. Niranjan Shintre. This video dives deep into two innovative approaches: autologous stem cell grafting, where your own stem cells are harvested and reinjected, and lab-processed donor stem cells, both designed to halt hair loss and rejuvenate hair growth. Dr. Shintre explains the […]
Promising Phase 1 Results for Hemophilia A Gene Therapy
Expression Therapeutics announced promising Phase 1 clinical trial results for its novel gene therapy, ET3, treating hemophilia A. The trial, detailed in the New England Journal of Medicine, showed significant increases in Factor VIII levels and a reduction in bleeding events in participants with severe hemophilia A. The therapy uses a lentiviral vector targeting hematopoietic stem […]